LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global active pharmaceutical ingredients (API) market report. This research report also lists 19 other prominent vendors that are expected to impact the market during the forecast period.
Globally, the synthetic production process, which involves the production of APIs from chemicals, was largely employed. However, the biotech production process is gaining prominence in recent years. This is owing to the disadvantages such as cross contamination and the difficulties associated with the purification of the APIs from the other synthesized compounds.
Competitive vendor landscape
The global APIs market is fragmented due to the presence of many vendors. The market comprises both core chemical and pharmaceutical companies and contract or custom manufacturers of APIs.
“The leading vendors in the API market compete based on price and innovation. These global vendors also face competition from regional vendors that are customer-centric and offer products at a lower cost,” says Ajay Adikari, a lead plastic, polymers, and elastomers research analyst from Technavio.
Request a sample report: http://www.technavio.com/request-a-sample?report=55045
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Top five active pharmaceutical ingredients market vendors
Aurobindo Pharma
Aurobindo Pharma is one of the leading manufacturers of APIs. It has a technologically advanced infrastructure for the R&D of APIs and commercializes more than 200 APIs. Five of its manufacturing facilities are approved by the US FDA, MHRA of the UK, the Therapeutic Goods Administration (TGA) of Australia, ANVISA of Brazil, and other reputed regulatory agencies. The company is among the few players that offer beta-lactam and non-beta-lactam antibiotics. It also offers penicillins, cephalosporins, anti-retroviral, anti-infectives, and sterile and non-sterile antibiotics.
Cipla
Cipla manufactures more than 200 generic and complex APIs. It covers a broad spectrum of therapeutic categories that are supplied to a few major formulation players in the pharmaceutical industry globally. It also has a pipeline of 50 APIs at various stages of development.
The company also has long-standing relationships with its existing partners on many APIs to support them in establishing leading positions in their markets. It has a network of modern APIs manufacturing facility, approved by the FDA and other major international regulatory agencies.
Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories’ API business caters to the innovator and generic companies across the US, Europe, Latin America, Japan, Korea and other emerging markets. The company has technical expertise in the development of complex APIs such as steroids, peptides, complex long chain synthesis, and cancer drugs. The company is partnered with many leading innovator companies to introduce their molecules to the market.
Sun Pharmaceutical Industries
Sun Pharmaceutical Industries has more than 45 advanced APIs and finished dose manufacturing sites in India, Bangladesh, Malaysia, the US, Brazil, Canada, Mexico, Hungary, Ireland, Romania, Israel, Egypt, Morocco, Nigeria, and South Africa.
The company provides APIs in full range of dosage forms including tablets, capsules, injectables, ointments, creams, and liquids. The company also manufactures specialty APIs such as controlled substances, steroids, peptides and anti-cancer agents.
Teva Pharmaceutical Industries
Tapi, a standalone business segment of Teva Pharmaceutical Industries, supplies APIs to nearly 1,000 customers in more than 100 countries. The company provides 300 APIs manufactured at 19 production facilities.
Browse Related Reports:
- Global Pharmaceutical Contract Manufacturing Market 2016-2020
- Global Pharmaceutical Packaging Equipment Market 2016-2020
- Global Pharmaceutical Caps and Closures Market 2016-2020
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like industrial gases, metals and minerals, and olefins. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.
About Technavio
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
